As we age, our cells enter a state called senescence. These harmful cells do not support the cells of which they are a part, and as we grow older, their accumulation is one of the key factors of aging. A new class of drugs known as senolytics focuses on the destruction of these cells from the body in order to improve tissue function and increase human healthspans.


Our analyst team reviews an emerging trend with interested listeners — alternating between Healthcare and Agriculture — outlining macro-trends, industry sub-sectors, key influencers, market leaders, and potential investment opportunities. Register here.